Literature DB >> 21166595

Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity.

Otto Haller1, Georg Kochs.   

Abstract

The human myxovirus resistance protein 1 (MxA) is a key mediator of the interferon-induced antiviral response against a wide range of viruses. MxA expression is tightly regulated by type I and type III interferons, requires signal transducer and activator of transcription 1 signaling, and is not inducible directly by viruses or other stimuli. MxA shares many properties with the dynamin superfamily of large GTPases. It consists of 3 domains, namely, an N-terminal GTPase domain that binds and hydrolyses GTP, a middle domain mediating self-assembly, and a carboxy-terminal GTPase effector domain. Like dynamin, MxA has the ability to self-assemble into highly ordered oligomers and to form ring-like structures around liposomes, inducing liposome tubulation. The structural details of MxA oligomerization have recently been elucidated, providing new insights into the antiviral mechanism of this mechanochemical enzyme. The structural and functional data suggest that MxA targets the nucleoprotein of MxA-sensitive viruses. Thus, MxA may form oligomeric rings around tubular nucleocapsid structures, thereby inhibiting their transcriptional and replicative function. Here we briefly review the most salient features of MxA expression and antiviral function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21166595     DOI: 10.1089/jir.2010.0076

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  138 in total

1.  Contraction of the type I IFN locus and unusual constitutive expression of IFN-α in bats.

Authors:  Peng Zhou; Mary Tachedjian; James W Wynne; Victoria Boyd; Jie Cui; Ina Smith; Christopher Cowled; Justin H J Ng; Lawrence Mok; Wojtek P Michalski; Ian H Mendenhall; Gilda Tachedjian; Lin-Fa Wang; Michelle L Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-22       Impact factor: 11.205

2.  MxB/Mx2: the latest piece in HIV's interferon puzzle.

Authors:  Oliver T Fackler; Oliver T Keppler
Journal:  EMBO Rep       Date:  2013-11-01       Impact factor: 8.807

3.  The myxovirus resistance A (MxA) gene -88G>T single nucleotide polymorphism is associated with prostate cancer.

Authors:  Shanora Glymph; Sanjay Mandal; Ashley Evans Knowell; Fisseha Abebe; Jaideep Chaudhary
Journal:  Infect Genet Evol       Date:  2013-02-22       Impact factor: 3.342

4.  Restriction of HIV-1 Requires the N-Terminal Region of MxB as a Capsid-Binding Motif but Not as a Nuclear Localization Signal.

Authors:  Bianca Schulte; Cindy Buffone; Silvana Opp; Francesca Di Nunzio; Daniel Augusto De Souza Aranha Vieira; Alberto Brandariz-Nuñez; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

5.  Contribution of MxB oligomerization to HIV-1 capsid binding and restriction.

Authors:  Cindy Buffone; Bianca Schulte; Silvana Opp; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

6.  Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity.

Authors:  Alexej Dick; Laura Graf; Daniel Olal; Alexander von der Malsburg; Song Gao; Georg Kochs; Oliver Daumke
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

7.  Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.

Authors:  Katia Monteleone; Pierluigi Di Maio; Giulia Cacciotti; Francesca Falasca; Maurizio Fraulo; Mario Falciano; Ivano Mezzaroma; Gabriella D'Ettorre; Ombretta Turriziani; Carolina Scagnolari
Journal:  Med Microbiol Immunol       Date:  2014-02-20       Impact factor: 3.402

Review 8.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

9.  Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.

Authors:  Megan Moerdyk-Schauwecker; Nirav R Shah; Andrea M Murphy; Eric Hastie; Pinku Mukherjee; Valery Z Grdzelishvili
Journal:  Virology       Date:  2012-12-14       Impact factor: 3.616

10.  Structural insight into HIV-1 restriction by MxB.

Authors:  Jennifer L Fribourgh; Henry C Nguyen; Kenneth A Matreyek; Frances Joan D Alvarez; Brady J Summers; Tamaria G Dewdney; Christopher Aiken; Peijun Zhang; Alan Engelman; Yong Xiong
Journal:  Cell Host Microbe       Date:  2014-10-09       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.